Articles dans des revues avec comité de lecture (30)
1.
Danieli, R., Stella, M., Leube, J., Tran-Gia, J., Marin, C., Uribe, C. F., Vanderlinden, B., Reynaert, N., Flamen, P., & Levillain, H. (2023). Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera. EJNMMI Physics, 10(1). doi:10.1186/s40658-023-00586-z2.
Willmann, J., Appelt, A. L., Balermpas, P., Baumert, B. G., de Ruysscher, D., Hoyer, M., Hurkmans, C., Kaidar-Person, O., Meattini, I., Niyazi, M., Poortmans, P., Reynaert, N., Tandini-Lang, S., van der Linden, Y., Nieder, C., & Andratschke, N. (2023). Re-irradiation in clinical practice: results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform. Radiotherapy and oncology, 109947. doi:10.1016/j.radonc.2023.1099473.
Burghelea, M., Bakkali Tahiri, J., Dhont, J., Kyndt, M., Gulyban, A., Szkitsak, J., Bogaert, E., Van Gestel, D., & Reynaert, N. (2023). Results of a multicenter 4D computed tomography quality assurance audit: Evaluating image accuracy and consistency. Physics and Imaging in Radiation Oncology, 28, 100479. doi:10.1016/j.phro.2023.1004794.
Bakkali Tahiri, J., Kyndt, M., Dhont, J., Gulyban, A., Szkitsak, J., Bogaert, E., Reynaert, N., & Burghelea, M. (2023). A comprehensive quality assurance program for four-dimensional computed tomography in radiotherapy. Physics and Imaging in Radiation Oncology, 27, 100475. doi:10.1016/j.phro.2023.1004755.
Paquier, Z., Chao, S.-L., Bregni, G., Sanchez Corujo, A., Guiot, T., Dhont, J., Gulyban, A., Levillain, H., Sclafani, F., Reynaert, N., & Bali, M. A. (2022). Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation. Physica medica, 103, 138-146. doi:10.1016/j.ejmp.2022.10.0096.
Andratschke, N., Willmann, J., Appelt, A., Alyamani, N., Balermpas, P., Baumert, B. B., Hurkmans, C., Høyer, M., Langendijk, J. A., Kaidar-Person, O., van der Linden, Y., Meattini, I., Niyazi, M., Reynaert, N., De Ruysscher, D. D., Tanadini-Lang, S., Hoskin, P., Poortmans, P., & Nieder, C. (2022). European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet oncology, 23(10), e469-e478. doi:10.1016/S1470-2045(22)00447-87.
Paquier, Z., Chao, S.-L., Acquisto, A., Fenton, C., Guiot, T., Dhont, J., Levillain, H., Gulyban, A., Bali, M. A., & Reynaert, N. (2022). Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values. Biomedical Physics & Engineering Express, 8(6), 065008. doi:10.1088/2057-1976/ac8e6f8.
Garibaldi, C., Essers, M., Heijmen, B., Bertholet, J., Koutsouveli, E., Schwarz, M., Bert, C., Bodale, M., Casares-Magaz, O., Gerskevitch, E., Koniarova, I., Korreman, S., Lisbona, A., Lopez Medina, A., Maas, A., Moeckli, R., Moore, M., Petrovic, B., Piotrowski, T., Poli, E., Prezado, Y., Reynaert, N., Redalen, K. R., Stylianou Markidou, E., Verellen, D., Jornet, N., & Clark, C. C. (2022). The 3rd ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy. Radiotherapy and oncology. doi:10.1016/j.radonc.2022.02.0129.
Ahrouch, I., Van Gestel, D., Koshariuk, O., Kirkove, C., Desmet, A., Philippson, C., Reynaert, N., & De Caluwe, A. (2021). Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: Differences between tangential beam and VMAT. Radiotherapy and oncology, 164, 282-288. doi:10.1016/j.radonc.2021.10.00510.
Kry, S. F., Lye, J., Clark, C. H., Andratschke, N., Dimitriadis, A., Followill, D., Howell, R., Hussein, M., Ishikawa, M., Kito, S., Kron, T., Lee, J., Michalski, J., Filippo Monti, A., Reynaert, N., Taylor, P., Venables, K., Xiao, Y., & Lehmann, J. (2021). Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency. Radiotherapy and oncology, 159, 106-111. doi:10.1016/j.radonc.2021.03.00612.
Kry, S. S., Lye, J., Clark, C. C., Andratschke, N., Dimitriadis, A., Followill, D., Howell, R., Hussein, M., Ishikawa, M., Kito, S., Kron, T., Lee, J., Michalski, J., Filippo Monti, A., Reynaert, N., Taylor, P., Venables, K., Xiao, Y., & Lehmann, J. (2021). Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency. Radiotherapy and oncology, 159, 106-111. doi:10.1016/j.radonc.2021.03.006